BNP Paribas Financial Markets’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,515
| Closed | -$28.8K | – | 4239 |
|
|
2020
Q4 | $28.8K | Sell |
2,515
-775
| -24% | -$8.83K | ﹤0.01% | 3765 |
|
|
2020
Q3 | $22.7K | Buy |
3,290
+2,351
| +250% | +$15.4K | ﹤0.01% | 3788 |
|
|
2020
Q2 | $6.12K | Sell |
939
-4,812
| -84% | -$31.1K | ﹤0.01% | 3916 |
|
|
2020
Q1 | $38K | Buy |
5,751
+2,031
| +55% | +$17.7K | ﹤0.01% | 3675 |
|
|
2019
Q4 | $38.6K | Buy |
3,720
+1,284
| +53% | +$11K | ﹤0.01% | 3783 |
|
|
2019
Q3 | $15.4K | Buy |
2,436
+186
| +8% | +$1.39K | ﹤0.01% | 4052 |
|
|
2019
Q2 | $16.7K | Sell |
2,250
-747
| -25% | -$4.93K | ﹤0.01% | 3956 |
|
|
2019
Q1 | $18.4K | Buy |
2,997
+2,517
| +524% | +$29.2K | ﹤0.01% | 3921 |
|
|
2018
Q4 | $5.53K | Sell |
480
-215
| -31% | -$3.67K | ﹤0.01% | 3551 |
|
|
2018
Q3 | $15K | Buy |
695
+4
| +0.6% | +$76 | ﹤0.01% | 3546 |
|
|
2018
Q2 | $10.9K | Sell |
691
-1,268
| -65% | -$19.9K | ﹤0.01% | 3737 |
|
|
2018
Q1 | $36.9K | Buy |
1,959
+163
| +9% | +$3.21K | ﹤0.01% | 3701 |
|
|
2017
Q4 | $31.3K | Buy |
1,796
+909
| +102% | +$12.5K | ﹤0.01% | 3862 |
|
|
2017
Q3 | $13.3K | Sell |
887
-35
| -4% | -$550 | ﹤0.01% | 3789 |
|
|
2017
Q2 | $17.1K | Buy |
922
+757
| +459% | +$13.2K | ﹤0.01% | 3747 |
|
|
2017
Q1 | $2.79K | Sell |
165
-78
| -32% | -$1.56K | ﹤0.01% | 3443 |
|
|
2016
Q4 | $5.17K | Sell |
243
-548
| -69% | -$11.2K | ﹤0.01% | 3698 |
|
|
2016
Q3 | $14.5K | Buy |
791
+446
| +129% | +$10.1K | ﹤0.01% | 3058 |
|
|
2016
Q2 | $9.99K | Buy |
+345
| New | +$9.6K | ﹤0.01% | 2914 |
|
BNP Paribas Financial Markets's ARA Position: Q1 2021 in Review
BNP Paribas Financial Markets sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 2,515 shares — an estimated $28.8K sold.
BNP Paribas Financial Markets first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $38.6K in Q4 2019. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- BNP Paribas Financial Markets reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 2,515 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $28.8K.
- BNP Paribas Financial Markets first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- BNP Paribas Financial Markets's American Renal Associates Holdings, Inc position peaked at $38.6K in Q4 2019.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.